NCT00786318撤回4 期
Prospective Double Blind Randomized Trial of Intramuscular Ziprasidone Compared With Standard Antipsychotic Therapy For The Treatment Of The Acutely Agitated Patient In The Emergency Department
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 撤回
- 试验地点
- 1
- 主要终点
- length of time from triage until patient is either ready to be seen by psychiatry or is ready to have a disposition made
研究概览
简要总结
The primary objective is to determine if ziprasidone is superior to standard therapies in the emergency department treatment of the acutely agitated patient. The primary outcome will be the length of time taken until the patient is ready to be evaluated by the psychiatric service, or until a disposition is made.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Acutely agitated
- •Requires chemical sedation
排除标准
- •Physician preference for a specific chemical sedative
- •Known allergy to any study medications
研究组 & 干预措施
ziprasidone
Experimental
干预措施: ziprasidone (Drug)
Standard therapy
Active Comparator
干预措施: Standard therapy (Drug)
结局指标
主要结局
length of time from triage until patient is either ready to be seen by psychiatry or is ready to have a disposition made
时间窗: During ED stay
次要结局
- Total time spent in restraints(ED visit)
- Length of time taken to sedate patient(Ed visit)
- Cost effectiveness of the therapy(ED visit)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)Bipolar DisorderPanic DisorderGeneralized Anxiety DisorderNCT01172652VA Palo Alto Health Care System49
终止
3 期
Safety And Efficacy Of Ziprasidone In Adolescents With SchizophreniaSchizophreniaNCT00257192Pfizer's Upjohn has merged with Mylan to form Viatris Inc.284
已完成
4 期
Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective DisorderPsychotic DisordersSchizophreniaNCT00137020Pfizer's Upjohn has merged with Mylan to form Viatris Inc.294
已完成
3 期
Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)Bipolar DisorderNCT00257166Pfizer's Upjohn has merged with Mylan to form Viatris Inc.238
终止
3 期
Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I DisorderBipolar DisorderNCT02075047Pfizer's Upjohn has merged with Mylan to form Viatris Inc.171